Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lind

Showing results (221-230 of 253) with videos related to

Pageof 26
Sort By:
Alimentary Pharmacology & Therapeutics|January 6, 2006
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagusM Vieth, M Kulig, A Leodolter, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2008
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control studyK Monkemuller, H Neumann, M Nocon, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trialT Lind, T Havelund, L Lundell, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2017
The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgeryL Mastracci, R Fiocca, C Engström, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2017
Editorial: the diminishing returns of normalisation of the oesophageal mucosa-Authors' replyL Mastracci, R Fiocca, C Engstrom, et al.
Scandinavian Journal of Gastroenterology|November 15, 1997
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic responseT Lind, T Havelund, R Carlsson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2006
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD studyD Jaspersen, J Labenz, S N Willich, et al.
Journal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2011
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD studyP Malfertheiner, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD StudyD Jaspersen, M Kulig, J Labenz, et al.
Pageof 26

Showing results (221-230 of 253) with videos related to

Sort By:
Pageof 26
Alimentary Pharmacology & Therapeutics|January 6, 2006
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagusM Vieth, M Kulig, A Leodolter, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2008
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control studyK Monkemuller, H Neumann, M Nocon, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trialT Lind, T Havelund, L Lundell, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2017
The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgeryL Mastracci, R Fiocca, C Engström, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2017
Editorial: the diminishing returns of normalisation of the oesophageal mucosa-Authors' replyL Mastracci, R Fiocca, C Engstrom, et al.
Scandinavian Journal of Gastroenterology|November 15, 1997
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic responseT Lind, T Havelund, R Carlsson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2006
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD studyD Jaspersen, J Labenz, S N Willich, et al.
Journal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2011
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD studyP Malfertheiner, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD StudyD Jaspersen, M Kulig, J Labenz, et al.
Pageof 26